13.3 C
New York
Saturday, December 9, 2023

Today, Olema Pharmaceuticals Inc (NASDAQ: OLMA) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Olema Pharmaceuticals Inc (OLMA) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.30, or 1.99%, to $15.35. The Olema Pharmaceuticals Inc has recorded 531 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $15.05 and fluctuated between $16.90 as its day high and $13.56 as its day low. The current market capitalization of Olema Pharmaceuticals Inc is $622.32M. A total of 0.76 million shares were traded on the day, compared to an average of 329.42K shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, OLMA has seen 4 BUY and 5 SELL insider trades, representing the acquisition of 1,605,488 and the disposition of 85,000 shares. Over the last 12 months, there were 5 BUYs and 8 SELLs from insiders. Insiders purchased 1,615,488 shares during that period but sold 105,000.

In the most recent transaction, Myles David C. sold 541 shares of OLMA for 17.51 per share on Nov 03. After the transaction, the CH. DISCOV. & NON-CLIN DEV OFF now owns 561,470 company shares. In a previous transaction on Nov 02, Harmon Cyrus sold 5,000 shares at 15.64 per share. OLMA shares that Director owns now total 943,714.

Among the insiders who sold shares, Myles David C. disposed of 3,332 shares on Nov 02 at a per-share price of $15.36. This resulted in the CH. DISCOV. & NON-CLIN DEV OFF holding 562,011 shares of OLMA after the transaction. In another insider transaction, Myles David C. sold 6,668 shares at $15.02 per share on Nov 01. Company shares held by the CH. DISCOV. & NON-CLIN DEV OFF now total 565,343.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for OLMA in the last 3 months, the mean price target is $25.00 with high estimates of $29.00 and low estimates of $21.00. In terms of 52-week highs and lows, OLMA has a high of $17.61 and a low of $2.19.

As of this writing, OLMA has an earnings estimate of -$0.51 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.69. The company reported an EPS of -$0.7 in the last quarter, which was -6.10% lower than expectations of -$0.66.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OLMA’s latest balance sheet shows that the firm has $287.25M in Cash & Short Term Investments as of fiscal 2021. There were $3.29M in debt and $9.02M in liabilities at the time. Its Book Value Per Share was $3.93, while its Total Shareholder’s Equity was $284.57M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OLMA is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles